Medication info
Daiyryl Em Tablet

Daiyryl Em Tablet

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201800310 · Approved 2018.01.23 · Insurance code 647204930

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine should be administered 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient’s current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and based on the results of blood glucose monitoring, it was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration schedule of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled dose.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes better control their blood sugar levels. It is particularly suitable for patients who follow dietary and exercise regimens, as the combined effects of glimepiride and metformin effectively lower blood sugar levels. This supports easy and stable blood sugar management in daily life, significantly aiding in the maintenance of healthy blood sugar levels for patients.

How to take

Adult dose

This medicine should be administered 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient’s current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient’s current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and based on the results of blood glucose monitoring, it was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration schedule of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled dose.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, it should be temporarily discontinued and consulted with a doctor if kidney function declines rapidly or if dehydration occurs. It should not be used in patients with impaired kidney function or liver dysfunction, pregnant women, breastfeeding mothers, and patients with certain metabolic acidosis. Elderly patients, those in a state of malnutrition, and patients with irregular meal intake who are at high risk of hypoglycemia should be monitored closely while on this medication. Gastrointestinal disturbances (such as diarrhea, nausea, vomiting, etc.) may commonly occur at the beginning of treatment, but they typically improve over time. This medication can reduce vitamin B12 levels, so regular blood tests to check vitamin B12 status are recommended for long-term use. There are numerous interactions with other medications, so it is essential to inform doctors or pharmacists when starting or stopping new medications, especially those that may affect kidney function. Caution should be exercised while driving or operating machinery, as hypoglycemia may impair concentration. Women who are pregnant or planning to become pregnant should not take this medication and should consider insulin therapy instead. In the event of an overdose, immediate medical attention is required, and if hypoglycemic symptoms occur, sugar intake or emergency care should be sought. This medication's safety and efficacy in children have not been sufficiently established, so special care is needed when used in this population. Regular monitoring of blood sugar levels, kidney function, and blood tests should be conducted to assess therapeutic effects and monitor for side effects. In the event of sudden infections, surgery, dehydration, etc., the administration of this medication should be stopped, and consultation with a doctor is necessary.

Side effects

lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, discomfort, metallic taste, visual impairment, taste disorder, erythema, itching, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, anemia, neutropenia, agranulocytosis, pancytopenia, peripheral neuropathy, increase in liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid stimulating hormone level, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, hypoglycemia, abdominal pain, abdominal distension, vomiting, dyspepsia, palpitations, dizziness, diarrhea, nausea, leg edema, cardiac arrest, rectal carcinoma, vertigo, liver dysfunction, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, headache, severe hunger, fatigue, sleep, weakness, drowsiness, sleep disturbances, instability, aggression, attention deficit, inability to focus, abnormal reactions, depressive feelings, confusion, language disorders, aphasia, tremors, paralysis, sensory disturbance, dizziness, loss of self-control, delirium, cerebral seizures, loss of consciousness, coma, weak respiration, slow pulse, sweating, clammy skin, anxiety, fast pulse, hypertension, palpitations, angina, deep vein thrombosis, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.